Advisers Latest

Trump Accounts for every child born in the U.S. from 2025 to 2028, the Saver's Match Program and auto portability represent a historic opportunity to move the needle.

Cost Plus Drugs co-founder berates benefit advisers for not emphasizing cash carveouts as he seeks to better educate CEOs on how to avoid being ripped off.

Teams that set their own rhythms and track their own goals will consistently outperform those shackled by oversight.

In light of the Republican proposal, we need to keep in mind that consumer-driven health care is a failed theory that will not deliver better health at a lower cost.

With premiums climbing, benefit leaders rely on claims data and analytic tools to guide smarter plan design and purchasing.

With about 7 million additional Americans expected to sign up for HSAs, these vehicles can help finance costly GLP-1s.

When care is seamless, employees are more likely to seek treatment early, which helps prevent avoidable complications and reduces costly downstream care.

The key to success lies in a value-based formulary, full disclosure from PBMs, real-time visibility into drug prices and unbiased prior authorization.

Just as organizations have developed sophisticated approaches to supporting new parents, similar strategic thinking can address elder caregiving challenges.

The industry asked for and received a delay in the rule from the IRS in 2023. Now that it's going into effect, here are the key implications for sponsors and savers.